selegiline has been researched along with u 0126 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holly, SP; Leisner, TM; Moran, C; Parise, LV | 1 |
1 other study(ies) available for selegiline and u 0126
Article | Year |
---|---|
CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling.
Topics: Butadienes; Calcium-Binding Proteins; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Humans; Immunoblotting; Immunohistochemistry; Iodoacetates; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasms; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; ras Proteins; RNA Interference; Selegiline; Signal Transduction | 2013 |